Interestingly, a high proportion of LAG-3+ T cells were found in a small subset of DLBCL patients unresponsive to Tisa-cel, highlighting the potential impact of this T-cell subset and clinical response (19). Here, LAG3 is linked to diffuse large B-cell lymphoma.